Dr. Kianoosh Keyhanian

Biography:

Dr. Kianoosh Keyhanian is a Pathologist at The Ottawa Hospital, focusing on gynecological, breast and ophthalmic pathology. She is also an Assistant Professor at the University of Ottawa where she teaches medical students, post-graduates and residents. Her research is focused on studying the molecular aspects of gynecological and breast malignancies.

Dr. Keyhanian received her MD from Isfahan University of Medical Sciences and her Masters in Neuroscience and Cellular and Molecular Medicine from University of Ottawa. Following that, Dr. Keyhanian joined Anatomical Pathology residency program at University of Ottawa for five years. In 2021, Dr. Keyhanian completed a fellowship in surgical pathology at Stanford Medicine, focusing on gynecologic pathology. 

Publications: 

Keyhanian, K., Mack, T., Forgo, E., Tazelaar, H. and Longacre, T.A., 2024. Female Adnexal Tumor of Probable Wolffian Origin (Wolffian Tumor): A Potential Mimic of Peritoneal Mesothelioma. The American Journal of Surgical Pathology, 48(8), pp.1041-1051.

Keyhanian, K., Han, L., Howitt, B.E. and Longacre, T., 2023. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing. The American Journal of Surgical Pathology, pp.10-1097.

Keyhanian, K., Yang, E.J. and Howitt, B.E., 2023. Nuclear β-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma. International Journal of Gynecological Pathology, 42(5), pp.435-442.

Keyhanian, K. and Sekhon, H.S., 2023. Do fine needle aspirate cytomorphological features correlate with positron emission tomography findings of metastatic non‐small cell lung carcinoma in lymph nodes?. Cancer Medicine, 12(7), pp.8218-8227.

Spears, M., Hopkins, M., Keyhanian, K., Robertson, S., Liao, L., Talebian, V., Awan, A.A., Pond, G.R., Bartlett, J., Bender, L.H. and Walters, I.B., 2023. Phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 in early stage breast cancer: The INVINCIBLE trial.

Keyhanian, K., Phillips, W.J., Yeung, B.S., Gomes, M., Lo, B. and Sekhon, H.S., 2022. Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma. Diagnostic Pathology, 17(1), p.46.

Keyhanian, K., Lage, J.M., Chernetsova, E., Sekhon, H., Eslami, Z. and Islam, S., 2020. Combination of MCM2 with Ki67 and p16 immunohistochemistry can distinguish uterine leiomyosarcomas. International Journal of Gynecological Pathology, 39(4), pp.354-361.

Chen, H.H., Keyhanian, K., Zhou, X., Vilmundarson, R.O., Almontashiri, N.A., Cruz, S.A., Pandey, N.R., Lerma Yap, N., Ho, T., Stewart, C.A. and Huang, H., 2015. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis. Circulation research, 117(8), pp.671-683.